Source: International Congress 2015 – Promising novel findings in translational pulmonary research
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
Paulina Jagus (Warsaw, Poland), Paulina Jagus, Pawel Krawczyk, Bartosz Wasag, Iwona Rzepecka, Piotr Wójcik, Karolina Tecza, Tomasz Powrozek, Bozena Konopka, Agata Gizycka, Kamila Wojas-Krawczyk, Janusz Limon, Barbara Pienkowska-Grela, Piotr Pierzchalski, Piotr Widlak, Joanna Chorostowska-Wynimko. EGFR mutation diagnostic program for NSCLC patients in Poland between 2011-2014. Eur Respir J 2015; 46: Suppl. 59, 4884

Member's Comments

No comment yet.

Related content which might interest you: Gefitinib in front line treatment of patients with NSCLC in the Czech Republic: Analysis of 113 patients Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014 Lung cancer in Berlin – NET of the lung; analysis of subgroups and impact on survival (2000 – 2008) Source: Annual Congress 2013 –Epidemiology, screening and diagnosis of lung cancer Year: 2013 Frequency and type of EGFR mutations in patients with adenocarcinoma of the lung Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer Year: 2013 EGFR mutation in non-small cell lung cancer(NSCLC) in South Croatia Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours Year: 2015 Prognostic value of EGFR mutation in NSCLC in surgical stage Source: International Congress 2014 – Biology and pathology of thoracic tumours Year: 2014 Second primary lung cancer in squamous NSCLC patients: The Nancy Biobank's database Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours Year: 2014 Gene expression of EGFR, MINA53,MEN1 and MTOR in NSCLCs Source: International Congress 2014 – Biology and pathology of thoracic tumours Year: 2014 Predictors of lung cancer patients delay time in Serbia - a cross-sectional study Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours Year: 2014 The prognostic value of KRAS mutation according to the gene's Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours Year: 2014 Regional pattern of trends in lung cancer incidence in Croatia, 2001-2013 Source: International Congress 2016 – Epidemiological aspects of tuberculosis and other respiratory conditions: from lung cancer to late-onset Pompe's disease Year: 2016 Clinical characteristics of 32 patients with BRAF V600E-mutated lung adenocarcinoma Source: International Congress 2015 – Advances in the therapy of lung cancer Year: 2015 ALK/EML4 translocation in non-squamous NSCLC and their predictors Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours Year: 2015 EGFR frequency and response to chemotherapy in a Brazilian NSCLC population Source: Annual Congress 2013 –Systemic therapy of lung cancer and quality of life Year: 2013 Review of stage 1/2 non-resected NSCLC against international guidance Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts Year: 2013 Improving survival for NSCLC patients in the national lung cancer audit Source: International Congress 2015 – Quality management in lung cancer Year: 2015 Improving NLST criteria for lung cancer screening Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014 Integrative analysis of DNA copy number in metastatic NSCLC identifies drug sensitivity to Afatinib Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours Year: 2014 Lung cancer, has it changed in the last ten years? Source: International Congress 2015 – Quality management in lung cancer Year: 2015 Methilation status in EBUS-NA samples of lung cancer Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014 Comorbitities, responses and survival in pts with NSCLC Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours Year: 2014